tiprankstipranks
American Healthcare REIT, Inc. (AHR)
NYSE:AHR
US Market

American Healthcare REIT, Inc. (AHR) AI Stock Analysis

Compare
134 Followers

Top Page

AH

American Healthcare REIT, Inc.

(NYSE:AHR)

72Outperform
American Healthcare REIT, Inc. receives a solid score of 72, driven by strong operational performance and positive future guidance. The stock shows significant upward momentum, although valuation challenges due to the absence of a P/E ratio and policy uncertainties present risks. The company's robust dividend yield and strategic investments enhance attractiveness, balancing the potential risks associated with asset leverage and sector-specific challenges.
Positive Factors
Balance Sheet Strength
With leverage cut in half within just one year, the company is providing a cleaner path toward both internal and external earnings growth.
Earnings Growth
American Healthcare REIT reported strong 3Q24 results, with Core FFO of $0.36 per share, outperforming expectations and reflecting higher NOI and lower interest expense.
Strategic Acquisitions
The company acquired the remaining minority interest in Trilogy, becoming its sole owner, and also acquired a senior housing portfolio, expanding its asset base.
Negative Factors
Lower FFO Estimates
Lowering FFO Estimates due to recent property dispositions and equity offering.
Lower Growth Expectations
Lower growth is expected going into 2025.
Multiple Reduction
The multiple has been updated to 18.0x from 19.5x.

American Healthcare REIT, Inc. (AHR) vs. S&P 500 (SPY)

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company DescriptionFormed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
How the Company Makes MoneyAmerican Healthcare REIT, Inc. generates revenue primarily through the leasing of its healthcare-related real estate properties. The company earns rental income from tenants, which include healthcare providers, senior living operators, and hospital systems. These rental agreements often involve long-term leases, providing AHR with a steady and predictable income stream. Additionally, AHR may engage in property management services and strategically sell properties to capitalize on market opportunities, further contributing to its revenue. Significant partnerships with healthcare operators and institutions also enhance the company's ability to maintain high occupancy rates and favorable lease terms, supporting its overall earnings.

American Healthcare REIT, Inc. Financial Statement Overview

Summary
American Healthcare REIT, Inc. demonstrates robust revenue growth and improved operational efficiency. Despite improvements in cash flow and debt reduction, the company struggles with maintaining profitability, as evidenced by recurring net losses. The balance sheet shows a strong equity position but indicates potential risks associated with asset leverage.
Income Statement
65
Positive
American Healthcare REIT, Inc. shows a strong revenue growth trajectory but suffers from negative net income, impacting profitability metrics. Gross profit margins have improved significantly over the years, indicating operational efficiency, yet net profit margins remain negative due to consistent net losses.
Balance Sheet
72
Positive
The company's balance sheet reflects stable equity growth and a substantial reduction in total debt, leading to a healthy debt-to-equity ratio of 0.0 in the latest fiscal year. However, the company's assets are heavily leveraged against equity, suggesting potential risk if asset values fluctuate.
Cash Flow
68
Positive
Cash flows have shown improvement with positive free cash flow growth and a strong operating cash flow to net income ratio. However, fluctuations in capital expenditures and financing activities indicate potential volatility in cash flow management.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
2.07B1.86B1.65B1.28B1.24B
Gross Profit
416.77M356.83M-145.91M81.10M119.54M
EBIT
136.78M76.72M450.47M133.19M98.86M
EBITDA
315.48M324.26M315.23M186.00M206.71M
Net Income Common Stockholders
-37.81M-71.47M-72.80M-52.31M5.79M
Balance SheetCash, Cash Equivalents and Short-Term Investments
76.70M43.45M111.91M125.49M152.19M
Total Assets
4.49B4.58B539.22M1.06B3.23B
Total Debt
1.87B3.02B64.86M57.53M1.88B
Net Debt
1.79B2.98B-47.05M-67.95M1.72B
Total Liabilities
2.18B3.12B661.00K2.62M2.16B
Stockholders Equity
2.26B1.27B4.79B4.58B866.11M
Cash FlowFree Cash Flow
84.15M-1.26M76.25M-64.49M81.82M
Operating Cash Flow
176.09M98.53M147.77M15.20M210.12M
Investing Cash Flow
-8.73M9.40M-123.76M-147.35M-137.04M
Financing Cash Flow
-134.74M-129.06M-37.74M102.81M-19.71M

American Healthcare REIT, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price30.45
Price Trends
50DMA
28.85
Positive
100DMA
28.19
Positive
200DMA
23.85
Positive
Market Momentum
MACD
0.37
Negative
RSI
58.21
Neutral
STOCH
81.43
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Positive. The current price of 30.45 is above the 20-day moving average (MA) of 29.61, above the 50-day MA of 28.85, and above the 200-day MA of 23.85, indicating a bullish trend. The MACD of 0.37 indicates Negative momentum. The RSI at 58.21 is Neutral, neither overbought nor oversold. The STOCH value of 81.43 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AHR.

American Healthcare REIT, Inc. Risk Analysis

American Healthcare REIT, Inc. disclosed 77 risk factors in its most recent earnings report. American Healthcare REIT, Inc. reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

American Healthcare REIT, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$96.09B177.753.32%1.75%20.40%57.80%
AHAHR
72
Outperform
$4.72B-2.14%3.38%11.17%
DODOC
72
Outperform
$14.57B55.863.29%5.89%23.82%-37.59%
HCHCP
70
Outperform
$7.11B-9.98%16.29%43.84%
VTVTR
63
Neutral
$29.99B343.000.80%2.64%9.48%
HRHR
60
Neutral
$5.92B-10.95%7.46%-5.62%-140.10%
55
Neutral
$4.58B-19.70-4.70%5.70%27.38%-68.17%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AHR
American Healthcare REIT, Inc.
30.31
16.57
120.60%
DOC
Healthpeak Properties
20.16
3.61
21.81%
WELL
Welltower
148.17
59.08
66.31%
VTR
Ventas
67.63
26.69
65.19%
HR
Healthcare Realty Trust
16.57
4.15
33.41%
HCP
HashiCorp
34.78
7.76
28.72%

American Healthcare REIT, Inc. Earnings Call Summary

Earnings Call Date: Feb 27, 2025 | % Change Since: 0.89% | Next Earnings Date: May 19, 2025
Earnings Call Sentiment Positive
The earnings call presented a strong performance for American Healthcare REIT in 2024, with significant growth in key segments such as Trilogy and a substantial reduction in leverage. The company has a positive outlook for 2025, with expectations for continued growth. However, challenges remain in the outpatient medical segment, and there are concerns regarding potential policy changes in healthcare. Despite these challenges, the robust performance and strategic investments position the company well for the coming year.
Highlights
Strong Same-Store NOI Growth
Total portfolio same-store NOI grew 21.6% year over year in the fourth quarter, with full year 2024 same-store NOI growth at 17.7% compared to 2023.
Trilogy Segment Performance
Trilogy segment's same-store NOI grew by 28% year over year in Q4 2024, and 23.8% for the full year. This segment is noted for its robust health outcomes and financial results.
Significant Reduction in Leverage
Net debt to adjusted EBITDA decreased from 8.5 times at the end of 2023 to 4.3 times at the end of 2024, enhancing financial flexibility.
Successful Capital Allocation Strategy
Invested over $650 million in external growth in managed long-term care segments in 2024 and announced new investments for 2025, including two new shop assets and several Trilogy development projects.
Positive Outlook for 2025
Guidance for 2025 includes 7% to 10% same-store NOI growth and $1.56 to $1.60 NFFO per share, anticipating double-digit NFFO per share growth.
Lowlights
Outpatient Medical Segment Challenges
Guidance for outpatient medical reflects headwinds from expected tenant move-outs, with predicted same-store NOI growth declines of 1.5% to 0.5%.
Q1 2025 Sequential Headwinds
Expectations of modest sequential headwinds to Trilogy NOI in Q1 2025 due to compensation-related expenses and seasonality, such as fewer days in Q1.
Potential Policy Changes Impact
Concerns about potential policy changes in the healthcare sector, primarily related to Medicaid, which could affect future operations and reimbursement rates.
Company Guidance
During the fourth quarter 2024 earnings call, American Healthcare REIT provided guidance for 2025, highlighting anticipated double-digit growth in key financial metrics. The company expects same-store NOI growth between 7% and 10%, with Trilogy and shop segments expected to lead with 10% to 12% and 18% to 22% growth, respectively. They project normalized funds from operations (NFFO) per share to increase to $1.56 to $1.60, reflecting strong operational performance and strategic investments. In 2024, American Healthcare REIT achieved a 17.7% growth in same-store NOI and reduced net debt to adjusted EBITDA from 8.5 times to 4.3 times. The company plans to continue pursuing accretive investments, having allocated over $650 million in 2024 to external growth initiatives, including Trilogy developments, and aims to leverage favorable market conditions and capital structure to capture future opportunities.

American Healthcare REIT, Inc. Corporate Events

Dividends
American Healthcare REIT Announces Quarterly Distribution
Neutral
Mar 19, 2025

On March 19, 2025, American Healthcare REIT, Inc. announced that its board of directors authorized a quarterly distribution of $0.25 per share for the first quarter of 2025, ending on March 31. This distribution, equating to an annualized rate of $1.00 per share, will be paid in cash on or about April 17, 2025, to shareholders of record as of March 31, 2025.

Private Placements and FinancingBusiness Operations and StrategyFinancial Disclosures
American Healthcare REIT Reports 2024 Financial Results
Neutral
Feb 27, 2025

On February 27, 2025, American Healthcare REIT, Inc. announced its financial results for the fourth quarter and full year of 2024, reporting a GAAP net loss attributable to controlling interest of $31.8 million for the quarter and $37.8 million for the year. Despite these losses, the company achieved significant Same-Store Net Operating Income (NOI) growth, particularly in its senior housing operating properties (SHOP) and integrated senior health campuses (ISHC) segments. The company also raised substantial capital through equity offerings and an at-the-market equity program, improving its balance sheet and positioning itself for continued growth in 2025. AHR’s strategic focus on senior housing investments has proven successful, with expectations for further growth driven by strong senior housing fundamentals.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.